What does a 40/200 dosage of a syrup mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Syrup 40/200 Dosage Notation

A 40/200 dosage designation in a syrup formulation indicates a combination product containing two active ingredients at concentrations of 40 mg and 200 mg per standard dosing unit (typically per 5 mL), respectively.

Dosage Notation Interpretation

The slash notation (40/200) represents a fixed-dose combination where:

  • The first number (40) indicates the amount of the first active ingredient in milligrams
  • The second number (200) indicates the amount of the second active ingredient in milligrams
  • Both amounts are typically expressed per standard volume unit (usually 5 mL for oral syrups) 1

Common Examples in Clinical Practice

Fixed-dose combination products use this notation format consistently:

  • Rifamate® capsules contain RIF (300 mg) and INH (150 mg), which could be expressed as 300/150 1
  • Rifater® tablets contain RIF (120 mg), INH (50 mg), and PZA (300 mg), expressed as 120/50/300 1
  • This standardized notation allows prescribers to quickly identify the exact composition of combination products 1

Clinical Application

When encountering a 40/200 syrup designation:

  • Verify the specific active ingredients from the product label or formulary, as the numbers alone don't identify which drugs are present 2
  • Confirm the volume per dose (typically 5 mL for syrups, but may vary) to calculate total daily intake accurately 1
  • Calculate weight-based dosing for pediatric patients by determining the mg/kg dose for each component separately 1

Important Considerations

Always consult the specific product labeling to confirm:

  • The identity of each active ingredient 2
  • The exact volume that contains the stated milligram amounts 1
  • Any special reconstitution or preparation requirements 3
  • Storage conditions and stability after opening 3

The notation system provides a standardized method for communicating fixed-dose combinations, but proper identification of the specific drug components remains essential for safe prescribing 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug Dosing Recommendations for All Patients: A Roadmap for Change.

Clinical pharmacology and therapeutics, 2021

Guideline

Reconstitution and Handling of Oral Urea Powder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dosage form design and development.

Clinical therapeutics, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.